Egan-Jones Recommends That Stockholders Vote the WHITE

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Egan-Jones Recommends That Stockholders Vote the WHITE Proxy Card in Support of RCM's Board Nominees

RCM Urges Stockholders to Vote WHITE Proxy Card and Reject the Legion Group's Problematic Nominees

PENNSAUKEN, N.J., Nov. 21, 2013 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (Nasdaq: RCMT ), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology, engineering and specialty healthcare services, today announced that Egan-Jones Proxy Services, a leading independent proxy advisory service, has recommended to its clients that stockholders vote the WHITE proxy card FOR both of the RCM Board of Directors' highly qualified and very experienced director nominees, Michael E.S. Frankel and Robert B. Kerr , at RCM's Annual Meeting of Stockholders to be held on December 5, 2013. Egan-Jones' clients include institutional investors, mutual funds, pension funds and other fiduciaries.

In recommending that stockholders vote the WHITE proxy card FOR both of the director nominees recommended by the RCM Board, Egan-Jones recognized the qualifications of the RCM Board's nominees and indicated that it believes that " voting FOR the management ballot and the Company's nominees is in the best interest of the Company and its stockholders " and that the election of the RCM Board's nominees will " enable the Company to continue to build on its strong record of increasing stockholder value . " Egan Jones also recognized RCM's efforts in strengthening its corporate governance practices, including RCM's termination of its stockholder rights plan, retention of a prominent executive search firm to enhance board composition, adoption of corporate governance guidelines reflective of best practices, declassification of its Board, adoption of majority voting in uncontested director elections, adoption of a director resignation policy, adoption of stock ownership guidelines for directors and executive officers and the appointment of a lead independent director.

Commenting on the nominees proposed by the Legion Group, Egan-Jones noted as follows: " We are not convinced that the dissidents' nominees would work to the benefit of the stockholders, given Mr. Vizi's apparent lack of public company board or public company management experience, and given Mr. Ballou's reported past experience as chairman and CEO of Global Vacation Group, Inc. and as president & CEO of CDI Corporation and his unsuccessful takeover attempt of RCM while there . "

"We are very pleased that a well−respected, independent third party such as Egan-Jones has carefully reviewed the voting alternatives and recommends that stockholders vote for RCM's highly qualified and experienced director nominees," said Leon Kopyt, RCM's Chairman and Chief Executive Officer.

To protect the value of their investment, the RCM Board strongly recommends that all stockholders vote for the RCM Board's highly qualified and experienced nominees – Michael E.S. Frankel and Robert B. Kerr – on the WHITE proxy card TODAY—by telephone, Internet, or by signing, dating and returning the WHITE proxy card.

Stockholders that need assistance in voting their shares or have any questions are urged to call RCM's proxy solicitor, Mackenzie Partners, Inc., at (800) 322-2885 (Toll Free) or at (212) 929-5500.

About RCM

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. RCM is an innovative leader in the delivery of these solutions to commercial and government sectors. RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America. Additional information can be found at www.rcmt.com .

Forward-Looking Statements

The Statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995 and are subject to various risks, uncertainties and other factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "believe," "plan," "seek," "could," "can," "should" or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company's services, expected demand for our services and expectations regarding our revenues, the Company's ability to continue to utilize goodwill, to continue to increase gross margins, to achieve and manage growth, to develop and market new applications and services, risks relating to the acquisition and integration of acquired businesses, the ability of the Company to consummate acquisitions as to which it executes non-binding letters of intent, demand for new services and applications, timing of demand for services, industry strength and competition and general economic factors. Such statements are based on current expectations that involve a number of known and unknown risks, uncertainties and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties and other factors may emerge from time to time that could cause the Company's actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties and other factors described in documents filed by the Company with the Securities and Exchange Commission. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Additional Information and Where to Find It

RCM, its directors and certain of its executive officers and employees are deemed to be participants in the solicitation of proxies from RCM's stockholders in connection with the 2013 Annual Meeting. RCM filed a definitive proxy statement and WHITE proxy card with the SEC in connection with the solicitation of proxies for the 2013 Annual Meeting on October 30, 2013 (the "2013 Proxy Statement"). STOCKHOLDERS ARE URGED TO READ THE 2013 PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT RCM WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Additional information regarding the identity of these participants and their direct or indirect interests, by security holdings or otherwise, is set forth in the 2013 Proxy Statement. To the extent holdings of RCM's securities have changed since the amounts shown in the 2013 Proxy Statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC.

Stockholders can obtain, free of charge, copies of the 2013 Proxy Statement and any other documents filed by RCM with the SEC in connection with the 2013 Annual Meeting at the SEC's website ( www.sec.gov ), at RCM's website ( www.rcmt.com ) or by writing to Mr. Kevin D. Miller, Chief Financial Officer, RCM Technologies, Inc., 2500 McClellan Avenue, Suite 350, Pennsauken, NJ 08109. In addition, copies of the proxy materials, when available, may be requested from RCM's proxy solicitor, MacKenzie Partners, Inc., 105 Madison Avenue, New York, NY 10016 or toll-free at (800) 322-2885.

RCM Technologies, Inc. 2500 McClellan Avenue Pennsauken, NJ 08109 Tel: 856.356.4500 Fax: 856.356.4600 www.rcmt.com Corporate Contacts: Leon Kopyt Chairman, President & CEO Kevin D. Miller Chief Financial Officer Investor Contacts: MacKenzie Partners, Inc. Paul Schulman or Robert Marese (212) 929-5500

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baidu Faces Class Action: Investors Push Against Fraud Allegations

Updated Category News Views 2

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 1

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 0

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 4

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 3

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 0

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 11

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 0

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 6

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 2

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading

Top 5 Most Recently Viewed Articles

NOV Inc. Announces Scheduled Cash Dividend for Shareholders

Updated Category News Views 124

NOV Inc. Announces Scheduled Cash Dividend for Shareholders HOUSTON — NOV Inc. (NYSE: NOV) is excited to share that the Board of Directors has recently made the decision to declare a quarterly cash dividend amounting to $0.075 per share. This dividend is set to be paid on December 19 to all stockholders who are on record as of December 5. The Role of NOV in the Energy...

Continue Reading
Enlivex Therapeutics Shares Promising Results for Osteoarthritis

Updated Category News Views 89

Enlivex Therapeutics Reports Positive Efficacy Data from Allocetra Trial Nes-Ziona, Israel – Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has announced encouraging interim results from its Phase I/II Allocetra™ trial focusing on patients with moderate to severe knee osteoarthritis. This randomized multi-country study marks a significant step forward in the company’s...

Continue Reading
Wing Yip Food Holdings Complete First Public Offering Success

Updated Category News Views 108

Wing Yip Food Holdings Completes Successful IPO Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) has successfully concluded its initial public offering (IPO), marking a significant milestone for the company. This meat processing company, operating subsidiaries in mainland China, raised approximately US$8.20 million through the offering of 2,050,000 American Depositary...

Continue Reading
Alkami Technology's Growth: Price Target Raised to $40

Updated Category News Views 30

Alkami Technology's Stock Outlook Enhanced Alkami Technology Inc (NASDAQ: ALKT) has recently captured the attention of investors and analysts alike with its impressive growth trajectory. According to recent reports, the price target for Alkami’s shares has been raised from $35 to $40 by Stephens, indicating a strong belief in the company’s continued success while...

Continue Reading
Confidein Secures $6 Million Seed Funding for Prayer Tech Expansion

Updated Category News Views 283

Confidein's Innovative Prayer Ring Initiative In an inspiring move, Confidein, a dedicated technology company at the intersection of faith and innovation, has successfully concluded a $6 million seed funding round. This funding, driven by influential Christian leaders and leading venture capitalists, sets the stage for a transformative campaign to benefit Christian...

Continue Reading